Wasting in Cancer

Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, United Kingdom

Progressive weight loss is a common feature of many types of cancer and is responsible not only for a poor quality of life and poor response to chemotherapy, but also a shorter survival time than is found in patients with comparable tumors without weight loss. Although anorexia is common, a decreased food intake alone is unable to account for the changes in body composition seen in cancer patients, and increasing nutrient intake is unable to reverse the wasting syndrome. Although energy expenditure is increased in some patients, cachexia can occur even with a normal energy expenditure. Various factors have been investigated as mediators of tissue wasting in cachexia. These include cytokines such as tumor necrosis factor- (TNF-), interleukin-6 (IL-6), interferon- (IFN-) and leukemia inhibitory factor (LIF), as well as tumor-derived factors such as lipid mobilizing factor (LMF) and protein mobilizing factor (PMF), which can directly mobilize fatty acids and amino acids from adipose tissue and skeletal muscle respectively. Induction of lipolysis by the cytokines is thought to result from an inhibition of lipoprotein lipase (LPL), although clinical studies provide no evidence for an inhibition of LPL in the adipose tissue of cancer patients. Instead there is an increased expression of hormone sensitive lipase, the enzyme activated by LMF. Protein degradation in cachexia is associated with an increased activity of the ATP-ubiquitin-proteasome pathway. The biological activity of both the LMF and PMF was shown to be attenuated by eicosapentaenoic acid (EPA). Clinical studies show that this polyunsaturated fatty acid is able to stabilize the rate of weight loss and adipose tissue and muscle mass in cachectic patients with unresectable pancreatic cancer. Knowledge of the mechanism of cancer cachexia should lead to the development of new therapeutic agents.

The Journal of Nutrition Vol. 129 No. 1 January 1999, pp. 243S-246S
Copyright ©1999 by the American Society for Nutritional Sciences

This article has been cited by other articles:

				J. L. Ryan, J. K. Carroll, E. P. Ryan, K. M. Mustian, K. Fiscella, and G. R. Morrow Mechanisms of Cancer-Related Fatigue Oncologist, May 1, 2007; 12(suppl_1): 22 - 34. [Abstract] [Full Text] [PDF]

				H. Bruunsgaard Physical activity and modulation of systemic low-level inflammation J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835. [Abstract] [Full Text] [PDF]

				M. Lafontan, C. Moro, C. Sengenes, J. Galitzky, F. Crampes, and M. Berlan An Unsuspected Metabolic Role for Atrial Natriuretic Peptides: The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2032 - 2042. [Abstract] [Full Text] [PDF]

				M. P. de la Maza, G. M. Agudelo, T. Yudin, V. Gattas, G. Barrera, D. Bunout, and S. Hirsch Long-Term Nutritional and Digestive Consequences of Pelvic Radiation J. Am. Coll. Nutr., April 1, 2004; 23(2): 102 - 107. [Abstract] [Full Text] [PDF]

				S. Kumar, H. Kishimoto, H. L. Chua, S. Badve, K. D. Miller, R. M. Bigsby, and H. Nakshatri Interleukin-1{alpha} Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer Am. J. Pathol., December 1, 2003; 163(6): 2531 - 2541. [Abstract] [Full Text] [PDF]

				P. Razeghi, S. Sharma, J. Ying, Y.-P. Li, S. Stepkowski, M. B. Reid, and H. Taegtmeyer Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation Circulation, November 18, 2003; 108(20): 2536 - 2541. [Abstract] [Full Text] [PDF]

				Y.-P. LI, S. H. LECKER, Y. CHEN, I. D. WADDELL, A. L. GOLDBERG, and M. B. REID TNF-{alpha} increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k FASEB J, June 1, 2003; 17(9): 1048 - 1057. [Abstract] [Full Text] [PDF]

				G. M. Diffee, K. Kalfas, S. Al-Majid, and D. O. McCarthy Altered expression of skeletal muscle myosin isoforms in cancer cachexia Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1376 - C1382. [Abstract] [Full Text] [PDF]

				T. A. Zimmers, M. V. Davies, L. G. Koniaris, P. Haynes, A. F. Esquela, K. N. Tomkinson, A. C. McPherron, N. M. Wolfman, and S.-J. Lee Induction of Cachexia in Mice by Systemically Administered Myostatin Science, May 24, 2002; 296(5572): 1486 - 1488. [Abstract] [Full Text] [PDF]

				R. DEBIGARE, C. H. COTE, and F. MALTAIS Peripheral Muscle Wasting in Chronic Obstructive Pulmonary Disease . Clinical Relevance and Mechanisms Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1712 - 1717. [Full Text] [PDF]

				M. P. Davis and E. D. Dickerson Thalidomide: Dual benefits in palliative medicine and oncology American Journal of Hospice and Palliative Medicine, September 1, 2001; 18(5): 347 - 351. [Abstract] [PDF]

				E. A. Patton, L. R. Brunet, A. C. La Flamme, J. Pedras-Vasconcelos, M. Kopf, and E. J. Pearce Severe Schistosomiasis in the Absence of Interleukin-4 (IL-4) Is IL-12 Independent Infect. Immun., January 1, 2001; 69(1): 589 - 592. [Abstract] [Full Text] [PDF]

				S. Al-Majid and D. O. McCarthy Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise Biol Res Nurs, January 1, 2001; 2(3): 186 - 197. [Abstract] [PDF]

				Y.-P. Li and M. B. Reid NF-kappa B mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1165 - R1170. [Abstract] [Full Text] [PDF]

				S. Leij-Halfwerk, P. C Dagnelie, J W. O van den Berg, J D. L Wattimena, C. H Hordijk-Luijk, and J. P. Wilson Weight loss and elevated gluconeogenesis from alanine in lung cancer patients1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 583 - 589. [Abstract] [Full Text] [PDF]

				M. W. Kennedy, A. P. Heikema, A. Cooper, P. J. Bjorkman, and L. M. Sanchez Hydrophobic Ligand Binding by Zn-alpha 2-glycoprotein, a Soluble Fat-depleting Factor Related to Major Histocompatibility Complex Proteins J. Biol. Chem., September 7, 2001; 276(37): 35008 - 35013. [Abstract] [Full Text] [PDF]